# REGENXBIO Inc. (RGNX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/rgnx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an adeno-associated virus-based gene delivery system. The company's primary investigational asset, RGX-314, is currently in Phase III clinical trials for treating wet age-related ma...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $6.69 USD |
| Market Cap | $441.6M |
| P/E (TTM) | — |
| EPS (TTM) | −$3.79 |
| 52-Week Range | $5.46 – $16.19 |
| Dividend Yield (TTM) | — |

## Dividend

RGNX has no dividend payment history in our records.

## Frequently Asked Questions

### What does REGENXBIO Inc. do?

REGENXBIO Inc. (RGNX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is RGNX's market cap?

REGENXBIO Inc. (RGNX) has a market capitalization of approximately $441.6 million, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does RGNX pay a dividend?

No, REGENXBIO Inc. (RGNX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is RGNX profitable?

REGENXBIO Inc. (RGNX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has RGNX ever paid a dividend?

No. Dividend Data's records show no dividend payments from REGENXBIO Inc. (RGNX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/rgnx
- Dividend history & safety: https://www.dividenddata.com/stocks/rgnx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/rgnx/earnings
- Financial statements: https://www.dividenddata.com/stocks/rgnx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/rgnx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/rgnx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.